Apex Biotechnology Corp. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was TWD 511.930 million compared to TWD 524.934 million a year ago. Operating income was TWD 15.087 million compared to TWD 34.660 million a year ago. Net income was TWD 11.968 million compared to TWD 21.738 million a year ago. Basic earnings per share was TWD 0.12 compared to TWD 0.22 a year ago. Diluted earnings per share was TWD 0.11 compared to TWD 0.2 a year ago.